Nalaganje...
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterized by a Th2 response, serum eosinophilia, and increased total serum IgE to Aspergillus fumigatus. ABPA occurs in cystic fibrosis (CF) and asthma. Omalizumab is a humanized recombinant monoclonal antibody against IgE...
Shranjeno v:
| izdano v: | J Asthma Allergy |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6016275/ https://ncbi.nlm.nih.gov/pubmed/29950869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S156049 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|